Medplus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, has received two suspension orders for drug licenses of its stores. The first order pertains to a store located in Jawahar Nagar, Telangana, with its drug license suspended for three days. This order was received on December 24, 2025, and is reportedly due to a violation under Rule 65 of the Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules, 1945. The potential revenue loss for this suspension is estimated at approximately ₹1.69 lacs. The second suspension order is for a store located in Radha Nagar-Kalyan, Maharashtra, where the drug license has been suspended for seven days. The authority issuing this order is the Food and Drug Administration, Mumbai, Maharashtra. The potential revenue loss associated with this suspension is estimated at approximately ₹3.85 lacs. These details are being shared pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/CIR/2023/123 dated July 13, 2023, read with SEBI Circular SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024. The information will be available on the company's website and the websites of BSE Limited and the National Stock Exchange of India Ltd.